Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization

Figure 2

Mean serum concentrations of Trastuzumab-Probiomed and the reference product versus time. Measurements were obtained after the administration of an intravenous single dose of 2 mg/kg in healthy volunteers. Vertical bars depict standard deviations.